Low renin hypertension

Area of Science:

• Nephrology
• Endocrinology
• Cardiovascular Medicine

Background:

• Low renin hypertension encompasses a range of conditions, including primary aldosteronism and other mineralocorticoid disorders.
• A significant portion of patients with low renin hypertension lack identifiable mineralocorticoid production abnormalities.
• Evidence indicates that volume excess plays a crucial role in the development of hypertension in these patients.

Purpose of the Study:

• To explore the spectrum of pathophysiology in low renin hypertension.
• To highlight the importance of further physiological studies for a comprehensive understanding.
• To review current evidence supporting treatment strategies for low renin hypertension.

Main Methods:

• Literature review of existing studies on low renin hypertension.
• Analysis of evidence implicating volume excess in disease pathogenesis.
• Evaluation of treatment efficacy based on published data.

Main Results:

• The largest group of patients with low renin hypertension shows no clear mineralocorticoid production defect.
• Volume excess is strongly suggested as a key factor in hypertension development.
• Diuretic therapy, specifically spironolactone or thiazides, is generally effective in normalizing blood pressure.

Conclusions:

• Low renin hypertension is a complex condition requiring further research into its pathophysiology.
• Despite ongoing studies, current evidence supports prompt treatment for these patients.
• Diuretic administration is a primary and effective therapeutic approach for managing low renin hypertension.